These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29354118)

  • 21. Hematopoietic and nonhematopoietic cells promote Type I interferon- and TLR7-dependent monocytosis during low-dose LCMV infection.
    Buechler MB; Gessay GM; Srivastava S; Campbell DJ; Hamerman JA
    Eur J Immunol; 2015 Nov; 45(11):3064-72. PubMed ID: 26289159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive but not inducible attenuation of transforming growth factor β signaling increases natural killer cell responses without directly affecting dendritic cells early after persistent viral infection.
    Lewis GM; Macal M; Hesser CR; Zuñiga EI
    J Virol; 2015 Mar; 89(6):3343-55. PubMed ID: 25589641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory monocytes recruited to the liver within 24 hours after virus-induced inflammation resemble Kupffer cells but are functionally distinct.
    Movita D; van de Garde MD; Biesta P; Kreefft K; Haagmans B; Zuniga E; Herschke F; De Jonghe S; Janssen HL; Gama L; Boonstra A; Vanwolleghem T
    J Virol; 2015 May; 89(9):4809-17. PubMed ID: 25673700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization.
    Denis J; Majeau N; Acosta-Ramirez E; Savard C; Bedard MC; Simard S; Lecours K; Bolduc M; Pare C; Willems B; Shoukry N; Tessier P; Lacasse P; Lamarre A; Lapointe R; Lopez Macias C; Leclerc D
    Virology; 2007 Jun; 363(1):59-68. PubMed ID: 17320136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus.
    Moskophidis D; Battegay M; van den Broek M; Laine E; Hoffmann-Rohrer U; Zinkernagel RM
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():381-91. PubMed ID: 7531218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering of papaya mosaic virus (PapMV) nanoparticles through fusion of the HA11 peptide to several putative surface-exposed sites.
    Rioux G; Babin C; Majeau N; Leclerc D
    PLoS One; 2012; 7(2):e31925. PubMed ID: 22363771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-alpha/beta.
    Sandberg K; Kemper P; Stalder A; Zhang J; Hobbs MV; Whitton JL; Campbell IL
    J Immunol; 1994 Jul; 153(1):220-31. PubMed ID: 8207238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Viral Antigen by the Liver Leads to Chronic Infection Through the Generation of Regulatory T Cells.
    Lapierre P; Janelle V; Langlois MP; Tarrab E; Charpentier T; Lamarre A
    Cell Mol Gastroenterol Hepatol; 2015 May; 1(3):325-341.e1. PubMed ID: 28210682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral Effect of Interferon Lambda Against Lymphocytic Choriomeningitis Virus.
    Lukacikova L; Oveckova I; Betakova T; Laposova K; Polcicova K; Pastorekova S; Pastorek J; Tomaskova J
    J Interferon Cytokine Res; 2015 Jul; 35(7):540-53. PubMed ID: 25830339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of correlation between serum titres of interferon alpha, beta, natural killer cell activity and clinical susceptibility in mice infected with two isolates of lymphocytic choriomeningitis virus.
    Leist TP; Aguet M; Hässig M; Pevear DC; Pfau CJ; Zinkernagel RM
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2213-8. PubMed ID: 3612089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipopolysaccharide inhibits the production of lymphocytic choriomeningitis virus in a human monocytic cell line.
    Krakauer T; Peters CJ
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1653-6. PubMed ID: 8345356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection.
    Xu HC; Huang J; Khairnar V; Duhan V; Pandyra AA; Grusdat M; Shinde P; McIlwain DR; Maney SK; Gommerman J; Löhning M; Ohashi PS; Mak TW; Pieper K; Sic H; Speletas M; Eibel H; Ware CF; Tumanov AV; Kruglov AA; Nedospasov SA; Häussinger D; Recher M; Lang KS; Lang PA
    J Virol; 2015 May; 89(9):4748-59. PubMed ID: 25673724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus.
    Martínez-Sobrido L; Zúñiga EI; Rosario D; García-Sastre A; de la Torre JC
    J Virol; 2006 Sep; 80(18):9192-9. PubMed ID: 16940530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN-I responses.
    Honke N; Shaabani N; Merches K; Gassa A; Kraft A; Ehrhardt K; Häussinger D; Löhning M; Dittmer U; Hengel H; Recher M; Lang PA; Lang KS
    Eur J Immunol; 2016 Feb; 46(2):372-80. PubMed ID: 26507703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-4 and IL-13 mediated down-regulation of CD8 expression levels can dampen anti-viral CD8⁺ T cell avidity following HIV-1 recombinant pox viral vaccination.
    Wijesundara DK; Jackson RJ; Tscharke DC; Ranasinghe C
    Vaccine; 2013 Sep; 31(41):4548-55. PubMed ID: 23933364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
    Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
    J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus.
    Sánchez AB; Perez M; Cornu T; de la Torre JC
    J Virol; 2005 Sep; 79(17):11071-81. PubMed ID: 16103158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.